Nationwide survey on the use of eltrombopag in patients with severe aplastic anemia: a report on behalf of the French Reference Center for Aplastic Anemia

Few therapeutic options are available for patients with aplastic anemia who are ineligible for transplantation or refractory to immunosuppressive therapy. Eltrombopag was recently shown to produce trilineage responses in refractory patients. However, the effects of real-life use of this drug remain...

Full description

Saved in:
Bibliographic Details
Published in:Haematologica
Main Authors: Lengline, Etienne, Drenou, Bernard, Peterlin, Pierre, Tournilhac, Olivier, Abraham, Julie, Berceanu, Ana, Dupriez, Brigitte, Guillerm, Gaelle, Raffoux, Emmanuel, de Fontbrune, Flore Sicre, Ades, Lionel, Balsat, Marie, Chaoui, Driss, Coppo, Paul, Corm, Selim, Leblanc, Thierry, Maillard, Natacha, Terriou, Louis, Socié, Gerard, de Latour, Regis Peffault
Format: Artigo
Language:Inglês
Published: Ferrata Storti Foundation 2018
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5792265/
https://ncbi.nlm.nih.gov/pubmed/29170252
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2017.176339
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items